Chester County News and Community Website
PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) has announced that its financial results for the third quarter of 2024 will be released after the market closes on November …
INOVIO Set to Unveil Q3 2024 Financial Results and Business Insights on November 14! Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced new data for its leading candidate, INO-3107, which could transform the treatment of recurrent respiratory papillomatosis (RRP). These findings, shared at the …
INOVIO Unveils Promising Data for INO-3107 in Treating RRP Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has recently issued equity grants to new employees as part of its 2022 Inducement Plan. Aimed at attracting top talent, these inducement grants are …
INOVIO Announces Equity Grants for New Employees Under 2022 Inducement Plan Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) is set to highlight its latest research in immunotherapy at several prestigious scientific conferences this October. These presentations will focus on INO-3107, a promising …
INOVIO to Showcase Advancements in Immunotherapy at Leading Scientific Conferences Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced its financial results for the second quarter of 2024 and provided an update on recent company developments. The company highlighted progress on …
INOVIO Reports Q2 2024 Financial Results and Provides Business Update Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced a significant milestone for its lead candidate, INO-3107, aimed at treating Recurrent Respiratory Papillomatosis (RRP). The European Medicines Agency’s Committee for …
INOVIO’s INO-3107 Receives European Certification for Quality and Data Compliance Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced that it will release its second-quarter 2024 financial results after the market closes on August 8, 2024. Following the announcement, the …
INOVIO to Release Q2 2024 Financial Results on August 8 Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has appointed Steven Egge as Chief Commercial Officer. Mr. Egge will spearhead the company’s commercial strategy and operations as it gears up for …
INOVIO Appoints Steven Egge as Chief Commercial Officer Amid Launch Preparations Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced this week the issuance of an equity grant to a newly hired employee under its 2022 Inducement Plan. The move aims to …
INOVIO Grants Equity Award to New Hire Under Inducement Plan Read More